Merck Exceeds Q2 Earnings and Revenue Estimates But Stock Drops 10% on Lowered Full-Year EPS Guidance
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameMerck&Co Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









